Abstract
In the last few years, the application of molecular studies in medicine has dramatically increased our knowledge of the biological basis of human diseases. This is evident not only for rare single-gene disorders, but also for many common disorders, including Crohn’s disease (CD).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Cho JH (2008) The genetics and immunopathogenesis of inflammatory bowel disease. Nat Rev Immunol 8:458–66
Geboes K, Colombel JF, Greenstein A et al (2008) Pathology Task Force of the International Organization of Inflammatory Bowel Diseases. Indeterminate colitis: a review of the concept—what’s in a name? Inflamm Bowel Dis 14:850–857
Cho JH, Weaver CT (2007) The genetics of inflammatory bowel disease. Gastroenterology 133:1327–1339
Shivananda S, Lennard-Jones J, Logan R et al (1996) Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut 39:690–697
Frangos CC, Frangos CC (2007) Inflammatory bowel disease: reviewing an old study under a new perspective. Gut 56:1638–1639
Yang H, Taylor KD, Rotter JI (2001) Inflammatory bowel disease. I. Genetic epidemiology. Mol Genet Metab 74:1–21
Thia KT, Loftus EV Jr, Sandborn WJ, Yang SK (2008) An update on the epidemiology of inflammatory bowel disease in Asia. Am J Gastroenterol 103:3167–3182
Andres PG, Friedman LS (1999) Epidemiology and the natural course of inflammatory bowel disease. Gastroenterol Clin North Am 28:255–281
Satsangi J, Jewell DP, Bell JI (1997) The genetics of inflammatory bowel disease. Gut 40:572–574
Binder V (1998) Genetic epidemiology in inflammatory bowel disease. Dig Dis 16:351–355
Tysk C, Lindberg E. Järnerot G et al (1988) Ulcerative colitis and Crohn’s disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. Gut 29:990–996
Thompson NP, Driscoll R, Pounder RE, Wakefield AJ (1996) Genetics versus environment in inflammatory bowel disease: results of a British twin study. BMJ 312:95–96
Orholm M, Binder V, Sørensen TI et al (2000) Concordance of inflammatory bowel disease among Danish twins. Results of a nationwide study. Scand J Gastroenterol 35:1075–1081
Halfvarson J, Bodin L, Tysk C et al (2003) Inflammatory bowel disease in a Swedish twin cohort: a long-term follow-up of concordance and clinical characteristics. Gastroenterology 124:1767–1773
Duerr RH, Taylor KD, Brant SR et al (2006) A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314:1461–1463
Fisher SA, Tremelling M, Anderson CA et al (2008) Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn’s disease. Nat Genet 40:710–712
Cho JH, Nicolae DL, Gold LH et al (1998) Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: evidence for epistasis between 1p and IBD1. Proc Natl Acad Sci U S A 95:7502–7507
Fowler EV, Eri R, Hume G et al (2005) TNFal pha and IL 10 SNPs act together to predict disease behaviour in Crohn’s disease. J Med Genet 42:523–528
Villani AC, Lemire M, Fortin G et al (2009) Common variants in the NLRP3 region contribute to Crohn’s disease susceptibility. Nat Genet 41:71–76
Nemetz A, Köpe A, Molnár T et al (1999) Significant differences in the interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms in a Hungarian population with inflammatory bowel disease. Scand J Gastroenterol 34:175–179
Hampe J, Franke A, Rosenstiel P et al (2007) A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet 39:207–211
Paavola P, Heliö T, Kiuru M et al (2001) Genetic analysis in Finnish families with inflammatory bowel disease supports linkage to chromosome 3p21. Eur J Hum Genet 9:328–334
Barrett JC, Hansoul S, Nicolae DL et al (2008) Genome-wide association defines more than 30 distinct susceptibility loci for Crohn’s disease. Nat Genet 40:955–962
Török HP, Glas J, Tonenchi L et al (2004) Crohn’s disease is associated with a toll-like receptor-9 polymorphism. Gastroenterology 127:365–366
Duerr RH, Barmada MM, Zhang L et al (2002) Evidence for an inflammatory bowel disease locus on chromosome 3p26: linkage, transmission/disequilibrium and partitioning of linkage. Hum Mol Genet 11:2599–2606
Pierik M, Joossens S, Van Steen K et al (2006) Toll-like receptor-1,-2, and-6 polymorphisms influence disease extension in inflammatory bowel diseases. Inflamm Bowel Dis 12:1–8
Karban AS, Okazaki T, Panhuysen CI et al (2004) Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis. Hum Mol Genet 13:35–45
Libioulle C, Louis E, Hansoul S et al (2007) Novel Crohn disease locus identified by genomewide association maps to a gene desert on 5p13. 1 and modulates expression of PTGER4. PLoS Genet 3:e58
Franke A, Balschun T, Karlsen TH et al (2008) Replication of signals from recent studies of Crohn’s disease identifies previously unknown disease loci for ulcerative colitis. Nat Genet 40:713–715
Peltekova VD, Wintle RF, Rubin LA et al (2004) Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat Genet 36:471–475
Silverberg MS, Duerr RH, Brant SR et al; NIDDK IBD Genetics Consortium (2007) Refined genomic localization and ethnic differences observed for the IBD5 association with Crohn’s disease. Eur J Hum Genet 15:328–335
Parkes M, Barrett JC, Prescott NJ et al (2007) Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn’s disease susceptibility. Nat Genet 39:830–832
Bouma G, Xia B, Crusius JB et al (1996) Distribution of four polymorphisms in the tumour necrosis factor (TNF) genes in patients with inflammatory bowel disease (IBD). Clin Exp Immunol 103:391–396
Stokkers PC, Reitsma PH, Tytgat GN, van Deventer SJ (1999) HLA-DR and-DQ phenotypes in inflammatory bowel disease: a meta-analysis. Gut 45:395–401
Orchard TR, Dhar A, Simmons JD et al (2001) MHC class I chain-like gene A (MICA) and its associations with inflammatory bowel disease and peripheral arthropathy. Clin Exp Immunol 126:437–440
McGovern DP, Hysi P, Ahmad T et al (2005) Association between a complex insertion/deletion polymorphism in NOD1 (CARD4) and susceptibility to inflammatory bowel disease. Hum Mol Genet 14:1245–1250
Cantor MJ, Nickerson P, Bernstein CN (2005) The role of cytokine gene polymorphisms in determining disease susceptibility and phenotype in inflammatory bowel disease. Am J Gastroenterol 100:1134–1142
Brant SR, Panhuysen CI, Nicolae D et al (2003) MDRI Ala893 polymorphism is associated with inflammatory bowel disease. Am J Hum Genet 73:1282–1292
Kyo K, Muto T, Nagawa H et al (2001) Associations of distinct variants of the intestinal mucin gene MUC3A with ulcerative colitis and Crohn’s disease. J Hum Genet 46:5–20
Dideberg V, Kristjansdottir G, Milani L et al (2007) An insertion-deletion polymorphism in the interferon regulatory Factor 5 (IRF5) gene confers risk of inflammatory bowel diseases. Hum Mol Genet 16:3008–3016
Yamazaki K, McGovern D, Ragoussis J et al (2005) Single nucleotide polymorphisms in TN-FSF15 confer susceptibility to Crohn’s disease. Hum Mol Genet 14:3499–3506
Franchimont D, Vermeire S, El Housni H et al (2004) Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn’s disease and ulcerative colitis. Gut 53:987–992
Rioux JD, Xavier RJ, Taylor KD et al (2007) Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet 39:596–604
Stoll M, Corneliussen B, Costello CM et al (2004) Genetic variation in DLG5 is associated with inflammatory bowel disease. Nat Genet 36:476–80
Tamura K, Fukuda Y, Sashio H et al (2002) IL18 polymorphism is associated with an increased risk of Crohn’s disease. J Gastroenterol 37 (Suppl 14):111–116
Yang H, Ohmen JD, Ma Y et al (1999) Additional evidence of linkage between Crohn’s disease and a putative locus on chromosome 12. Genet Med 1:194–198
Duerr RH, Barmada MM, Zhang L et al (2000) High-density genome scan in Crohn disease shows confirmed linkage to chromosome 14q11-12. Am J Hum Genet 66:1857–1862
Glas J, Török HP, Unterhuber H et al (2003) The-295T-to-C promoter polymorphism of the IL-16 gene is associated with Crohn’s disease. Clin Immunol 106:197–200
Hampe J, Frenzel H, Mirza MM et al (2002) Evidence for a NOD2-independent susceptibility locus for inflammatory bowel disease on chromosome 16p. Proc Natl Acad Sci U S A 99:321–326
Hampe J, Cuthbert A, Croucher PJ et al (2001) Association between insertion mutation in NOD2 gene and Crohn’s disease in German and British populations. Lancet 357:1925–1928
Hugot JP, Chamaillard M, Zouali H et al (2001) Association of NOD2 leucine-rich repeat vari-with susceptibility to Crohn’s disease. Nature 411:599–603
Rioux JD, Silverberg MS, Daly MJ et al (2000) Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. Am J Hum Genet 66:1863–1870
Latiano A, Palmieri O, Valvano MR et al (2008) The association of MYO9B gene in Italian patients with inflammatory bowel diseases. Aliment Pharmacol Ther 27:241–248
McGovern DP, Butler H, Ahmad T et al (2006) TUCAN (CARD8) genetic variants and inflammatory bowel disease. Gastroenterology 131:1190–1196
Ogura Y, Bonen DK, Inohara N et al (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature 411:603–606
Inohara N, Ogura Y, Fontalba A et al (2003) Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn’s disease. J Biol Chem 278:5509–5512
Kobayashi KS, Chamaillard M, Ogura Y et al (2005) Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 307:731–734
Cavanaugh JA, Adams KE, Quak EJ et al (2003) CARD15/NOD2 risk alleles in the development of Crohn’s disease in the Australian population. Ann Hum Genet 67:35–41
Yamazaki K, Takazoe M, Tanaka T et al (2002) Absence of mutation in the NOD2/CARD15 gene among 483 Japanese patients with Crohn’s disease. J Hum Genet 47:469–472
Croucher PJ, Mascheretti S, Hampe J et al (2003) Haplotype structure and association to Crohn’s disease of CARD15 mutations in two ethnically divergent populations. Eur J Hum Genet 11:6–16
Leong RW, Armuzzi A, Ahmad T et al (2003) NOD2/CARD15 gene polymorphisms and Crohn’s disease in the Chinese population. Aliment Pharmacol Ther 17:1465–1470
Kugathasan S, Loizides A, Babusukumar U et al (2005) Comparative phenotypic and CARD15 mutational analysis among African American, Hispanic, and White children with Crohn’s disease. Inflamm Bowel Dis 11:631–638
Economou M, Trikalinos TA, Loizou KT et al (2004) Differential effects of N0D2 variants on Crohn’s disease risk and phenotype in diverse populations: a metaanalysis. Am J Gastroenterol 99:2393–2404
Annese V, Lombardi G, Perri F et al (2005) Variants of CARD15 are associated with an aggressive clinical course of Crohn’s disease — an IG-IBD study. Am J Gastroenterol 100:84–92
Crawford NP, Colliver DW, Eichenberger MR et al (2007) CARD15 genotype-phenotype relationships in a small inflammatory bowel disease population with severe disease affection status. Dig Dis Sci 52:2716–2724
Wiekowski MT, Leach MW, Evans EW et al (2001) Ubiquitous transgenic expression of the IL-23 subunit p19 induces multiorgan inflammation, runting, infertility, and premature death. J Immunol 166:7563–7570
Yen D, Cheung J, Scheerens H et al (2006) IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest 116:1310–1316
Cummings SA, Rubin DT (2006) The complexity and challenges of genetic counseling and testing for inflammatory bowel disease. J Genet Couns 15:465–476
Lindberg E, Tysk C, Andersson K, Järnerot G (1988) Smoking and inflammatory bowel disease. A case control study. Gut 29:352–357
Calkins BM (1989) A meta-analysis of the role of smoking in inflammatory bowel disease. Dig Dis Sci 34:1841–1854
Sandler RS, Wurzelmann JL, Lyles CM (1992) Oral contraceptive use and the risk of inflammatory bowel disease. Epidemiology 3:374–378
Brant SR, Picco MF, Achkar JP et al (2003) Defining complex contributions of NOD2/CARD15 gene mutations, age at onset, and tobacco use on Crohn’s disease phenotypes. Inflamm Bowel Dis 9:281–289
Gleason TR, Evans ME (2004) Perceived vulnerability: a comparison of parents and children. J Child Health Care 8:279–287
Grosse SD, Khoury MJ (2006) What is the clinical utility of genetic testing? Genet Med 8:448–450
Pierik M, Rutgeerts P, Vlietinck R, Vermeire S (2006) Pharmacogenetics in inflammatory bowel disease. World J Gastroenterol 12:3657–3667
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag Italia
About this chapter
Cite this chapter
Castori, M., Grammatico, P. (2010). Genetics. In: Tersigni, R., Prantera, C. (eds) Crohn’s Disease. Updates in Surgery. Springer, Milano. https://doi.org/10.1007/978-88-470-1472-5_3
Download citation
DOI: https://doi.org/10.1007/978-88-470-1472-5_3
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-1471-8
Online ISBN: 978-88-470-1472-5
eBook Packages: MedicineMedicine (R0)